(Q78194765)

English

Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention

scientific article published on 01 August 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10468074%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10468074%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

unstable angina

1 reference

based on heuristic

inferred from title

Dean J Kereiakes

1

object named as

D J Kereiakes

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10468074%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

Charles W. Abbottsmith

11

object named as

C W Abbottsmith

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10468074%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

author name string

T M Broderick

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10468074%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

E M Roth

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10468074%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

D Whang

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10468074%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

T Shimshak

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10468074%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

J P Runyon

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10468074%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

C Hattemer

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10468074%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

J Schneider

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10468074%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

P Lacock

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10468074%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

M Mueller

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10468074%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

publication date

1 August 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10468074%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10468074%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

84

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10468074%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10468074%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

391-395

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10468074%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

Blockade of Platelet GPIIb/IIIa Receptors as an Antithrombotic Strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900321-5

7 January 2021

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900321-5

7 January 2021

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900321-5

7 January 2021

Rapid and simple platelet function assay to assess glycoprotein IIb/IIIa receptor blockade.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900321-5

7 January 2021

Rapid assessment of platelet function with a modified whole-blood aggregometer in percutaneous transluminal coronary angioplasty patients receiving anti-GP IIb/IIIa therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900321-5

7 January 2021

Rapid platelet-function assay: an automated and quantitative cartridge-based method

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900321-5

7 January 2021

Efficacy of abciximab induced platelet blockade using a rapid point of care assay

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900321-5

7 January 2021

The Effect of Thrombocytopenia on the Determination of Platelet Aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900321-5

7 January 2021

Platelet hyperreactivity and prognosis in survivors of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900321-5

7 January 2021

Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900321-5

7 January 2021

Randomized, double-blind, placebo-controlled dose-ranging study of tirofiban (MK-383) platelet IIb/IIIa blockade in high risk patients undergoing coronary angioplasty.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900321-5

7 January 2021

Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900321-5

7 January 2021

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900321-5

7 January 2021

Pharmacodynamic study of F(ab')2 fragments of murine monoclonal antibody 7E3 directed against human platelet glycoprotein IIb/IIIa in patients with unstable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900321-5

7 January 2021

Monoclonal antibodies to platelet glycoprotein IIb/IIIa as antithrombotic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900321-5

7 January 2021

Differential inhibition of platelet aggregation induced by adenosine diphosphate or a thrombin receptor-activating peptide in patients treated with bolus chimeric 7E3 Fab: Implications for inhibition of the internal pool of GPIIb/IIIa receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900321-5

7 January 2021

Erythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an antithrombotic therapeutic modality: the effect of low-dose aspirin is less than optimal in patients with vascular disease due to prothrombotic effects of eryt

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900321-5

7 January 2021

Effect of Ca2+ on GP IIb-IIIa interactions with integrilin: enhanced GP IIb-IIIa binding and inhibition of platelet aggregation by reductions in the concentration of ionized calcium in plasma anticoagulated with citrate

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900321-5

7 January 2021

Differential effects of glycoprotein IIb/IIIa antagonists on platelet microaggregate and macroaggregate formation and effect of anticoagulant on antagonist potency. Implications for assay methodology and comparison of different antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900321-5

7 January 2021

New approaches to antiplatelet therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900321-5

7 January 2021

Identifiers

10.1016/S0002-9149(99)00321-5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10468074%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10468074%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q78194765&oldid=1723238616"